Research Article

Diagnostic Accuracy of Platelet Count and Platelet Indices in Noninvasive Assessment of Fibrosis in Nonalcoholic Fatty Liver Disease Patients

Table 3

Clinical, laboratory, and demographic data of NAFLD patients compared to controls.

NAFLDControl cases value

Age51.8 ± 14.650.4 ± 14.1>0.05
Gender: male/female56/4232/28>0.05
BMI29.3 ± 4.726.2 ± 3.6<0.01
Waist circumference109.4 ± 8.9108.2 ± 6.6<0.05
Systolic BP130.3 ± 8.9124 ± 6.6<0.01
Diastolic BP82.6 ± 6.481.5 ± 4.4>0.05
Glucose6.6 ± 2.045.8 ± 1.5<0.01
Urea6.5 ± 5.96.6 ± 7.5>0.05
Creatinine77.5 ± 15.273.3 ± 21.1>0.05
Total cholesterol5.78 ± 1.15.72 ± 1.4>0.05
LDL cholesterol3.6 ± 0.92.6 ± 1.1<0.01
HDL cholesterol1.2 ± 0.61.7 ± 0.4<0.01
Triglyceride2.4 ± 1.71.7 ± 0.9<0.01
AST33.1 ± 19.322.3 ± 11.2<0.01
ALT46.1 ± 25.822.1 ± 7.8<0.01
ALP72.3 ± 23.073 ± 19.2>0.05
GGT73.6 ± 82.944 ± 12.1<0.01
WBC7.02 ± 1.77.2 ± 2.6>0.05
PC218.4 ± 56.8255.3 ± 77.9<0.01
MPV9.1 ± 1.37.6 ± 1.1<0.01
PDW16.7 ± 0.715.9 ± 0.7<0.01
PCT0.2 ± 0.10.1 ± 0.0<0.01